ATAI Life Sciences NV
NASDAQ:ATAI

Watchlist Manager
ATAI Life Sciences NV Logo
ATAI Life Sciences NV
NASDAQ:ATAI
Watchlist
Price: 1.19 USD Market Closed
Market Cap: 199.7m USD
Have any thoughts about
ATAI Life Sciences NV?
Write Note

ATAI Life Sciences NV
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ATAI Life Sciences NV
Total Other Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
ATAI Life Sciences NV
NASDAQ:ATAI
Total Other Income
$88.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck KGaA
XETRA:MRK
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
MPH Health Care AG
XETRA:93M1
Total Other Income
-€576k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Total Other Income
€2k
CAGR 3-Years
26%
CAGR 5-Years
15%
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

ATAI Life Sciences NV
Glance View

Market Cap
199.7m USD
Industry
Pharmaceuticals

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company engages in the treatment of mental health disorders. The company is headquartered in Berlin, Berlin and currently employs 81 full-time employees. The company went IPO on 2021-06-18. The firm is aiming to transform the treatment of mental health disorders.

ATAI Intrinsic Value
0.02 USD
Overvaluation 98%
Intrinsic Value
Price

See Also

What is ATAI Life Sciences NV's Total Other Income?
Total Other Income
88.8m USD

Based on the financial report for Dec 31, 2023, ATAI Life Sciences NV's Total Other Income amounts to 88.8m USD.

What is ATAI Life Sciences NV's Total Other Income growth rate?
Total Other Income CAGR 1Y
13 160%

Over the last year, the Total Other Income growth was 13 160%.

Back to Top